| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.991 | 7.044 | 7.441 | 4.075 | 5.096 | 13.156 | 26.478 | 37.376 | 45.502 | 35.136 |
| Total Income - EUR | 6.991 | 7.044 | 7.442 | 5.339 | 6.808 | 14.960 | 31.531 | 44.586 | 42.023 | 45.282 |
| Total Expenses - EUR | 16.992 | 6.430 | 7.106 | 5.149 | 27.711 | 14.507 | 30.294 | 43.799 | 40.312 | 44.669 |
| Gross Profit/Loss - EUR | -10.001 | 614 | 336 | 190 | -20.903 | 453 | 1.237 | 787 | 1.711 | 613 |
| Net Profit/Loss - EUR | -10.211 | 403 | 204 | 116 | -20.954 | 239 | 542 | 98 | 1.255 | 262 |
| Employees | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pavmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.871 | 2.516 | 11.306 | 10.616 | 18.833 | 26.580 | 32.464 | 40.124 | 36.491 | 47.516 |
| Current Assets | 2.031 | 3.233 | 9.640 | 11.829 | 6.297 | 10.452 | 24.945 | 12.750 | 7.796 | 18.073 |
| Inventories | 1.852 | 2.344 | 7.042 | 10.432 | 0 | 3.017 | 0 | 7.210 | 3.594 | 13.709 |
| Receivables | 85 | 0 | 1.477 | 1.196 | 5.522 | 4.245 | 13.690 | 3.810 | 1.987 | 3.926 |
| Cash | 94 | 889 | 1.121 | 202 | 774 | 3.191 | 11.255 | 1.731 | 2.215 | 439 |
| Shareholders Funds | -19.865 | -19.260 | -18.730 | -18.271 | -38.870 | -37.894 | -36.512 | -36.528 | -35.162 | -34.704 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 24.767 | 25.009 | 39.676 | 41.361 | 64.000 | 74.927 | 93.921 | 89.402 | 79.448 | 100.293 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Pavmed Srl